Dr Clive Dix

Clive has more than 30 years’ experience through senior pharmaceutical industry positions and a Pharmacology BSc 1st Class Hons and PhD from University of Leeds. His expertise includes an in-depth understanding of Drug Discovery and development, a broad knowledge of the science and commercial landscape across therapeutic areas and solid experience of the pharmaceutical business and finance community supporting the sector.Clive is CEO of C4X Discovery, Non-Executive Chairman of Centauri Ltd and a Non Executive Board member of the Medicines Discovery Catapult. He was Co-Founder and CEO of Convergence Pharmaceuticals Ltd, acquired by Biogen, and Co-Founder and CEO of PowderMed Ltd, acquired by Pfizer. Previously, he was SVP, Research and Development and a Board member of PowderJect Pharmaceuticals plc, acquired by Chiron Vaccines. Clive began his career in industry at Ciba-Geigy and GlaxoWellcome. Clive was Chairman of the BioIndustry Association and interim Chair of the UK Vaccines taskforce, the group set up by the Government to tackle the COVID-19 pandemic and oversee the supply of one of the most successful vaccine rollout programmes in the world.